Acceptability of cognitive remediation for schizophrenia: a systematic review and meta-analysis of randomized controlled trials

被引:46
|
作者
Vita, Antonio [1 ,2 ]
Barlati, Stefano [1 ,2 ]
Ceraso, Anna [1 ]
Deste, Giacomo [2 ]
Nibbio, Gabriele [1 ]
Wykes, Til [3 ,4 ]
机构
[1] Univ Brescia, Dept Clin & Expt Sci, Brescia, Italy
[2] ASST Spedali Civili Brescia, Dept Mental Hlth & Addict Serv, Brescia, Italy
[3] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychol, London, England
[4] Maudsley Hosp & Inst Psychiat, South London & Maudsley NHS Fdn Trust, Denmark Hill, London, England
关键词
Acceptability; cognitive remediation; drop-out; meta-analysis; schizophrenia; systematic review; PSYCHOSOCIAL TREATMENT; TRAINING-PROGRAM; LOW-SUPPORT; THERAPY; ADHERENCE; EFFICACY; OUTCOMES; IMPACT; BLIND; RATES;
D O I
10.1017/S0033291722000319
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background Acceptability is an important factor for predicting intervention use and potential treatment outcomes in psychosocial interventions. Cognitive remediation (CR) improves cognition and functioning in people with a diagnosis of schizophrenia, but its acceptability, and the impact of participants and treatment characteristics, remain to be investigated. Few studies provide a direct measure of acceptability, but treatment drop-out rates are often available and represent a valid surrogate. Method The systematic search conducted for the most comprehensive CR outcomes database for schizophrenia was updated in December 2020. Eligible studies were randomized clinical trials comparing CR with any other control condition in patients diagnosed with schizophrenia spectrum disorders and that also reported drop-out in treatment and control arms separately. Acceptability was measured as odd-ratios (OR) of drop-out. Results Of 2119 identified reports, 151 studies, reporting 169 comparisons between CR and control interventions with 10 477 participants were included in the analyses. The overall rate of drop-out was 16.58% for CR programs and 15.21% for control conditions. In the meta-analysis, no difference emerged between CR interventions and controls [OR 1.10, 95% confidence interval (CI) 0.96-1.25, p = 0.177]. Factors improving acceptability were: inpatient only recruitment, participants with fewer years of education and lower premorbid IQ, the presence of all CR core elements, and the presence of techniques to transfer cognitive gains into real-world functioning. Conclusions CR for people diagnosed with schizophrenia is effective and has a good acceptability profile, similar to that of other evidence-based psychosocial interventions.
引用
收藏
页码:3661 / 3671
页数:11
相关论文
共 50 条
  • [11] Efficacy and Tolerability of Perospirone in Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Taro Kishi
    Nakao Iwata
    CNS Drugs, 2013, 27 : 731 - 741
  • [12] Efficacy and acceptability of varenicline for alcoholism: A systematic review and meta-analysis of randomized-controlled trials
    Oon-arom, Awirut
    Likhitsathain, Surinporn
    Srisurapanont, Manit
    DRUG AND ALCOHOL DEPENDENCE, 2019, 205
  • [13] Rehabilitation of Cognitive Deficits Poststroke: Systematic Review and Meta-Analysis of Randomized Controlled Trials
    O'Donoghue, Mairead
    Leahy, Siobhan
    Boland, Pauline
    Galvin, Rose
    McManus, John
    Hayes, Sara
    STROKE, 2022, 53 (05) : 1700 - 1710
  • [14] The Efficacy and Acceptability of Third-Wave Behavioral and Cognitive eHealth Treatments: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    O'Connor, Martin
    Munnelly, Anita
    Whelan, Robert
    McHugh, Louise
    BEHAVIOR THERAPY, 2018, 49 (03) : 459 - 475
  • [15] Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
    Zhu, Gui-Qi
    Zou, Zhuo-Lin
    Zheng, Ji-Na
    Chen, Da-Zhi
    Zou, Tian-Tian
    Shi, Ke-Qing
    Zheng, Ming-Hua
    MEDICINE, 2016, 95 (09)
  • [16] Systematic Review, Meta-Analysis and Randomized Controlled Trials in Cytopathology
    AbdullGaffar, Badr
    ACTA CYTOLOGICA, 2012, 56 (03) : 221 - 227
  • [17] injury: A systematic review and meta-analysis of randomized controlled trials
    Daou, Marietou
    Dionne, Joanna C.
    Teng, Jennifer F. T.
    Taran, Shaurya
    Zytaruk, Nicole
    Cook, Deborah
    Wilcox, M. Elizabeth
    JOURNAL OF CRITICAL CARE, 2022, 71
  • [18] Blonanserin for schizophrenia: Systematic review and meta-analysis of double-blind, randomized, controlled trials
    Kishi, Taro
    Matsuda, Yuki
    Nakamura, Hiroshi
    Iwata, Nakao
    JOURNAL OF PSYCHIATRIC RESEARCH, 2013, 47 (02) : 149 - 154
  • [19] Physical exercise for negative symptoms of schizophrenia: Systematic review of randomized controlled trials and meta-analysis
    Sabe, Michel
    Kaiser, Stefan
    Sentissi, Othman
    GENERAL HOSPITAL PSYCHIATRY, 2020, 62 : 13 - 20
  • [20] Efficacy and acceptability of psilocybin for primary or secondary depression: A systematic review and meta-analysis of randomized controlled trials
    Fang, Shuping
    Yang, Xin
    Zhang, Wei
    FRONTIERS IN PSYCHIATRY, 2024, 15